Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Formulation Design and Evaluation of an Emulgel Containing Terminalia arjuna Bark Extract for Transdermal Delivery

    Dinanath Tukaram Gaikwad1★, Namdeo Ramhari Jadhav1★ Corresponding author

    1. 1Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur, Maharashtra, India.

    CORRESPONDENCE

    Dinanath Tukaram Gaikwad

    Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur, Maharashtra, India.

    dinanath.gaikwad@bharatividyapeeth.edu

    Received: 07-12-2017; Revised: 10-01-2018.

    Volume 14, Issue 55s · pp. S249–S255 · PUBLISHED 28 June 2018 · DOI: 10.4103/pm.pm_578_17

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: Terminalia arjuna is used in various indigenous system of medicine such as Ayurveda, Siddha, and Unani. The traditional medical forms provide drug delivery with peaks often above the required dose and face problems such as first‑pass metabolism, stability, and low therapeutic efficacy. To enhance topical delivery and to allow for controlled release, the use of T. arjuna bark extract emulgel was explored. Objective: The objective of this study is to design and develop novel emulgel formulation of T. arjuna bark extract for transdermal delivery. Materials and Methods: Pseudoternary phase diagram was developed using aqueous titration method. Appropriate amount of oil, surfactant, and cosurfactant were mixed together in accordance with obtained emulsion region in the phase diagram. The emulsion was prepared and incorporated in gel base. The four different formulations were evaluated for physical examinations, rheological studies, skin irritation studies, in vitro release, and ex vivo release studies. Results: The phase diagram at Km value 3 showed better emulsion existence regions. Formulation F3 showed maximum release, wherein the amount of the extract released after 720 min was 91.43%. Skin irritation test on albino rats resulted no allergic symptoms such as inflammation, redness, and irritation up to 72 h. All the prepared emulgel formulations were found to be stable on storage. Conclusion: It can be concluded that T. arjuna bark extract emulgel can be used for transdermal delivery for the treatment of chronic ailments such as pulmonary hypertension.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Gaikwad, D. T., & Jadhav, N. R. (2018). Formulation Design and Evaluation of an Emulgel Containing Terminalia arjuna Bark Extract for Transdermal Delivery. Pharmacognosy Magazine, 14(55s), S249–S255. https://doi.org/10.4103/pm.pm_578_17